Sashi S. Kommu
Dr Sashi S. Kommu is an Associate Professor in Uro-oncology and Cancer Biology in The School of Biosciences; The University of Kent, United Kingdom. He is also a Consultant Pelvic Cancer Urological Surgeon with a subspecialty interest in minimally invasive management of urological cancers including laparoscopic and robotic urological surgery at East Kent Hospitals University NHS Foundation Trust. He leads The National Institute for Health Research (NIHR) for all surgical specialties for Kent, Surrey and Sussex in the U.K. His key clinical interests are in the minimally invasive management of urological cancers, surgical robotics and intelligent probes. He has done formal research at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research with The Translational Cancer Genetics Team where he refined his scientific methodology in advanced laboratory work with an emphasis on cancer genetics and proteomics. He has also gained vast exposure in nanotechnology. He has over 100 peer-reviewed publications in respected scientific and medical journals including The Lancet. He also has over 300 scientific presentations, several book chapters and books. Dr Kommu has over 25 academic awards including The Olympus Award at The 25th World Congress of Endourology in Cleveland U.S.A. 2006. He has nine pending patents including a cost-effective Telerounding Kit for Remote Teleconsultations, which was presented at The House of Commons (Hosted by The British Parliament) in 2006. His ability to blend medical science with engineering and technology has earned him two NASA collaborative scientific commendations. Dr Kommu is reviewer for 15 surgical/urological and 3 basic sciences journals. Several novel concepts described by Dr Kommu include ‘suppressor screening in urological cancer screening’ and ‘the supplementary biomarker approach’ for detecting cancers.